CSL share price: Plunging US vaccination rates ravages Australian global pharmaceutical giant on ASX
admin 13 hours agoLatest NewsComments Off on CSL share price: Plunging US vaccination rates ravages Australian global pharmaceutical giant on ASX0 Views
The Melbourne-based blood-products company plans to cut $500 million in costs in response to slowing sales growth. Here is what’s behind the drop.
